Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWSulfapyridine is a sulfonamide antibiotic with antibacterial and anti-inflammatory activities.1 It is also a metabolite of sulfasalazine (Item No. 15025) formed through bacterial conversion in the colon.2 It is active against strains of Y. enterocolitica and Salmonella (MICs = 3.1-25 and 25-100 μg/ml, respectively), as well as S. aureus (MBC = 0.8 μM).3,4 It is an inhibitor of recombinant P. carinii dihydropteroate synthetase (DHPS; IC50 = 0.18 μM).5 Sulfapyridine scavenges peroxyl radicals in an oxygen radical absorbance capacity (ORAC) assay.2 It inhibits histamine release induced by compound 48/80 (Item No. 22173) from isolated rat peritoneal mast cells in a dose-dependent manner.6 Sulfapyridine (1 μg/kg) also inhibits compound 48/80-induced systemic allergic reaction in rats. Formulations containing sulfapyridine have previously been used in the treatment of dermatological conditions and ulcerative colitis.
WARNING This product is not for human or veterinary use.
1. Sulfapyridine and sulfone type drugs in dermatology. Arch. Dermatol. 85(1), 42-56 (1962).
2. Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-
3. In vitro susceptibility of diarrhoea producing gram negative enteric bacteria to sulfasalazine, 5-
4. Studies on the antibacterial action of the sulfonamide drugs: II. The possible relation of drug activity to substances other than p-
5. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs. Antimicrob. Agents Chemother. 39(8), 1756-1763 (1995).
6. Inhibitory effect of mast cell-